Publication:
Does Medication related Osteonecrosis of the Jaw Affect Maxillary Sinus Volume and Mucosal Thickness?

Simple item page
dc.contributor.authorYILMAZ ASAN, CANAY
dc.contributor.authorGÖNEN, ZEYNEP BURÇİN
dc.contributor.authorKILIÇ, Erdem
dc.contributor.authorALKAN, Alper
dc.contributor.institutionauthorAKKOYUN, EMİNE FULYA
dc.contributor.institutionauthorKILIÇ, ERDEM
dc.contributor.institutionauthorALKAN, ALPER
dc.date.accessioned2020-10-29T22:21:20Z
dc.date.available2020-10-29T22:21:20Z
dc.date.issued2020-04-01T00:00:00Z
dc.description.abstractObjective: Bisphosphonates (BPs) are commonly prescribed drugs because of their antiresorptive effects. However, BPs may cause medication-related osteonecrosis of the jaw (MRONJ). This study aimed to compare the maxillary sinus volumes and mucosal thickening of patients with MRONJ and healthy patients.
dc.identifier.citationYILMAZ ASAN C., GÖNEN Z. B. , Akkoyun E. F. , KILIÇ E., ALKAN A., -Does Medication related Osteonecrosis of the Jaw Affect Maxillary Sinus Volume and Mucosal Thickness?-, MEANDROS MEDICAL AND DENTAL JOURNAL, cilt.21, ss.12-18, 2020
dc.identifier.doi10.4274/meandros.galenos.2018.44366
dc.identifier.urihttp://hdl.handle.net/20.500.12645/26563
dc.identifier.wosWOS:000543352900002
dc.titleDoes Medication related Osteonecrosis of the Jaw Affect Maxillary Sinus Volume and Mucosal Thickness?
dc.typeArticle
dspace.entity.typePublication
local.avesis.idae6e143a-c757-4fec-84f7-6d3f472d1f5b
local.indexed.atWOS
local.publication.isinternational1
relation.isAuthorOfPublicationfe2511fe-5c76-4389-b734-e4c171482e9f
relation.isAuthorOfPublication960911c0-f159-46fb-acf1-866dc1b0b842
relation.isAuthorOfPublicationf621b6f2-1415-4076-b3a2-78835a8712bd
relation.isAuthorOfPublication.latestForDiscoveryfe2511fe-5c76-4389-b734-e4c171482e9f

Files

Collections

Yayınlar - Eserler